News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,737 Results
Type
Article (56162)
Company Profile (71)
Press Release (588504)
Multimedia
Podcasts (60)
Webinars (12)
Section
Business (174759)
Career Advice (2708)
Deals (32790)
Drug Delivery (104)
Drug Development (76229)
Employer Resources (155)
FDA (14988)
Job Trends (14036)
News (306464)
Policy (29702)
Tag
Academia (2696)
Academic (2)
Accelerated approval (6)
Adcomms (24)
Allergies (89)
Alliances (43912)
ALS (86)
Alzheimer's disease (1309)
Antibody-drug conjugate (ADC) (114)
Approvals (15000)
Artificial intelligence (268)
Autoimmune disease (23)
Automation (15)
Bankruptcy (299)
Best Places to Work (10933)
BIOSECURE Act (20)
Biosimilars (102)
Biotechnology (47)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (274)
Cancer (2212)
Cardiovascular disease (166)
Career advice (2294)
Career pathing (33)
CAR-T (159)
Cell therapy (436)
Cervical cancer (20)
Clinical research (62082)
Collaboration (810)
Company closure (1)
Compensation (328)
Complete response letters (21)
COVID-19 (2528)
CRISPR (44)
C-suite (260)
Cystic fibrosis (101)
Data (2154)
Decentralized trials (1)
Denatured (25)
Depression (44)
Diabetes (252)
Diagnostics (6233)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (40)
Drug discovery (116)
Drug pricing (115)
Drug shortages (23)
Duchenne muscular dystrophy (84)
Earnings (61046)
Editorial (40)
Employer branding (19)
Employer resources (135)
Events (95717)
Executive appointments (759)
FDA (16256)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (743)
Gene editing (111)
Generative AI (21)
Gene therapy (296)
GLP-1 (665)
Government (4573)
Grass and pollen (6)
Guidances (65)
Healthcare (18396)
Huntington's disease (19)
IgA nephropathy (23)
Immunology and inflammation (110)
Indications (28)
Infectious disease (2664)
Inflammatory bowel disease (135)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (96)
Interviews (522)
IPO (14967)
IRA (49)
Job creations (3485)
Job search strategy (1924)
Kidney cancer (10)
Labor market (31)
Layoffs (506)
Leadership (21)
Legal (6688)
Liver cancer (70)
Lung cancer (309)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (286)
MASH (63)
Medical device (12628)
Medtech (12633)
Mergers & acquisitions (18396)
Metabolic disorders (638)
Multiple sclerosis (78)
NASH (15)
Neurodegenerative disease (82)
Neuropsychiatric disorders (26)
Neuroscience (1826)
NextGen: Class of 2025 (6434)
Non-profit (4434)
Now hiring (15)
Obesity (328)
Opinion (241)
Ovarian cancer (74)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (140)
Partnered (21)
Patents (235)
Patient recruitment (114)
Peanut (49)
People (58799)
Pharmaceutical (21)
Pharmacy benefit managers (15)
Phase I (19629)
Phase II (27449)
Phase III (19999)
Pipeline (1159)
Policy (146)
Postmarket research (2352)
Preclinical (8245)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (252)
Rare diseases (363)
Real estate (6042)
Recruiting (63)
Regulatory (20520)
Reports (33)
Research institute (2472)
Resumes & cover letters (404)
Rett syndrome (5)
RNA editing (3)
RSV (37)
Schizophrenia (67)
Series A (133)
Series B (84)
Service/supplier (9)
Sickle cell disease (53)
Special edition (12)
Spinal muscular atrophy (147)
Sponsored (27)
Startups (3377)
State (1)
Stomach cancer (10)
Supply chain (59)
Tariffs (31)
The Weekly (33)
Vaccines (673)
Venture capitalists (36)
Weight loss (208)
Women's health (30)
Worklife (20)
Date
Today (27)
Last 7 days (767)
Last 30 days (2350)
Last 365 days (30528)
2025 (10240)
2024 (32468)
2023 (36614)
2022 (46982)
2021 (51860)
2020 (50982)
2019 (45002)
2018 (34363)
2017 (30743)
2016 (30078)
2015 (35417)
2014 (28405)
2013 (24734)
2012 (26023)
2011 (26267)
2010 (24656)
Location
Africa (865)
Alabama (56)
Alaska (7)
Arizona (170)
Arkansas (13)
Asia (38717)
Australia (6781)
California (5569)
Canada (1849)
China (516)
Colorado (252)
Connecticut (260)
Delaware (142)
Europe (87417)
Florida (849)
Georgia (199)
Idaho (55)
Illinois (548)
India (25)
Indiana (277)
Iowa (9)
Japan (150)
Kansas (98)
Kentucky (25)
Louisiana (10)
Maine (60)
Maryland (833)
Massachusetts (4040)
Michigan (220)
Minnesota (343)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (22)
Nevada (57)
New Hampshire (68)
New Jersey (1640)
New Mexico (29)
New York (1643)
North Carolina (939)
North Dakota (8)
Northern California (2409)
Ohio (195)
Oklahoma (15)
Oregon (35)
Pennsylvania (1238)
Puerto Rico (11)
Rhode Island (28)
South America (1175)
South Carolina (18)
South Dakota (1)
Southern California (2134)
Tennessee (95)
Texas (852)
United States (21332)
Utah (173)
Virginia (140)
Washington D.C. (59)
Washington State (512)
West Virginia (3)
Wisconsin (59)
644,737 Results for "shanghai institute of materia medica simm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments
On November 17, 2021, Simcere Pharmaceutical Group Limited announced that the company has reached collaboration agreement with the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, to develop novel antiviral drugs for COVID-19.
November 22, 2021
·
3 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Business
PHASE II/III CLINICAL TRIAL OF SIMCERE’S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT
Simcere Pharmaceutical Group (2096.HK) announced today that, XIANNUOXI N (SIM 0417), an anti-SARS-CoV-2 drug candidate jointly developed by Simcere with Shanghai Institute of Materia Medica (the “SIMM”) and Wuhan Institute of Virology (the “WIV”), Chinese Academy of Sciences (the “CAS”), has achieved a major clinical milestone.
December 20, 2022
·
5 min read
Lone Star Bio
Barry Simms Named as Elligo Health Research’s Chief Operating Officer
Elligo Health Research®, the largest healthcare-enabling research organization, announced the addition of Barry Simms as Elligo’s Chief Operating Officer.
August 29, 2023
·
2 min read
Business
Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese Medicine
Universe Pharmaceuticals INC today announced that the Company had entered into two strategic cooperation agreements (the “Agreements”) with Jiangxi Province Institute of Materia Medica.
January 4, 2022
·
4 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
MEDSIR, Featured Company at the Shanghai International Medical Oncology Symposium (7th SIMOS)
December 3, 2024
·
4 min read
Press Releases
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
November 1, 2024
·
4 min read
Deals
Donaldson Enters into Agreement to Acquire Minority Stake in Medica, S.p.A.
Donaldson Company, Inc., a leading worldwide provider of innovative filtration products and solutions, announced it has entered into a definitive agreement allowing the Company to purchase a 49% stake in Medica S.p.A.
April 29, 2024
·
5 min read
Business
Outstanding Traditional Chinese Medicine Vitiligo Treatment Institution Establishes Itself in Shanghai, Aiming to Provide Specialized Treatment Solutions to More International Patients
Recently has unveiled a remarkable announcement: the inauguration of the Huahai Institute of Vitiligo Research in Shanghai.
September 26, 2023
·
5 min read
1 of 64,474
Next
